drugset / Trial / NCT03020784
Safety and Tolerability of PF-06818883 in Healthy Subjects
RandomizedDouble-blindTreatment
Summary
Safety, Tolerability and Pharmacokinetics of PF-06818883
Timeline
- Start
- 2016-11-11
- Primary completion
- 2017-06-13
- Completion
- 2017-06-13
Outcome
Outcome not reported
Stopped: “The study was terminated on 16JUN2017 for safety reasons”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PF-06818883 | Unknown | — | Intravenous |
Indications
No indication recorded.